TrialAnais brasileiros de dermatologia

Efficacy and safety of risankizumab versus methotrexate in patients with moderate-to-severe plaque psoriasis: results from IMMbrace, a randomized, double-blind, phase 3 study with an open-label extension period in Brazil.

Tania F Cestari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.